Replies to post #194392 on Anavex Life Sciences Corp (AVXL)

[XenaLives]

Your comment still misses the point..

People who take sleeping pills from time to time aren't in as much danger from sedative medications.

People who take sleeping pills frequently either have a CNS problem or are in danger of creating one with the medication.

In any case 2-73 is a safer alternative so no other proof will be needed if patients in all 3 trials are sleeping better.

You don't seem to understand the connection between sleep and CNS health. I suggest the post I made this AM on chronic disease and sleep and the other reading in this sticky:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149039117


Your observation is incorrect and your logic fails:

Yes about the sleep improvement.
On what basis would A273 be permitted if only as an improvement of sleep?
Would that be for people who take sleeping pils from time to time just because they have trouble sleeping and have no indications of CNS problems?
Or would that be for people who do have CNS problems and trouble sleeping and they could benefit from A273? In any case there is need of proof
And that proof is in the data of the read out. And if that read out is indicating it improves the problems of CNS then as a wonderful side effect sleep problems diminish. In other words... I do not see A 273 improve sleep for people with CNS problems if it does not help the underlying CNS problems. So then we are back where we were and that is to wait for the complete read out of the trials...